MAT

The “Black Box” of Treatment: Patients’ Perspective on What Works in Opioid Maintenance Treatment for Opioid Dependence

Scientific article

10 May 2021

Source: Silva, T.C., Andersson, F.B. The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence. Subst Abuse Treat Prev Policy 16, 41 (2021). https://doi.org/10.1186/s13011-021...

Delivering Medication Assisted Treatment for Addictions via Telehealth

2 March 2021

Online

This seminar marks the launch of a consultation process funded by the Drug Deaths Task Force (DDTF), Scottish Government and Corra Foundation on best practice approaches on delivering Medication-Assisted Treatment (MAT) for Opioid Use Disorder via Telehealth.

Geographic Proximity to Buprenorphine Treatment Providers in the U.S.

Scientific article

Abstract Objective To combat the growing opioid epidemic, people who use drugs need access to medications for opioid use disorder (MOUD) as part of comprehensive treatment. Despite progress, treatment gaps remain. Our objective was to use a...

Drug Use and COVID-19 in Prisons: First Clinic Dedicated to the Treatment of People Living in Prisons with Opioid Use Disorders in Kenya

News

In 2018, Mombasa planned to set up a methadone programme for heroin injecting drug users living in prisons. As a follow up, UNODC worked together with the County of Mombasa and the Kenya Prison Service in 2019, to support and expand...

Mombasa County Chief Officer for Health, Coast Prison Commander and partners from the Civil Society Organizations before the start of operationalization of the Shimo La Tewa clinic in Mombasa

Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-Analysis

Scientific article

18 March 2020

Abstract Importance: The number of children with prenatal opioid exposure to medication for addiction treatment (MAT) with methadone and buprenorphine for maternal opioid use disorder is increasing, but the associations of this exposure...

Free Webinar: Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons

25 February 2020

Webinar

People who have been incarcerated are approximately 100 times more likely to die by overdose in the first two weeks after their release than the general public. Despite high rates of opioid use disorder among justice-involved individuals, evidence-based medications exist and can be successfully implemented within jails and prisons.

Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit

Website

Cannabis Use during Methadone Maintenance Treatment for Opioid Use Disorder: A Systematic Review and Meta-Analysis

Scientific article

19 November 2019

Abstract Background: Rates of cannabis use among patients receiving methadone maintenance therapy are high, and cannabis use may be associated with outcomes of methadone maintenance therapy. We examined the effect of cannabis use on opioid...

Journal for Advancing Justice Volume II

Book

Opioid-related morbidity and mortality in the U.S. has been steadily increasing over the last two decades. In 2017 alone, 2.1 million Americans suffered from opioid use disorder (OUD), and 47,600 died from opioid overdose. Predictably, the...

Criminal Justice Continuum for Opioid Users at Risk of Overdose

Scientific article

27 February 2018

Worldwide, there has been a dramatic rise in the number of opioid-involved overdose deaths. Certain sections of the population are more vulnerable to the risk of developing opioid use disorder and overdosing. One such group are those in the...